Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 Dec;81(3):405-14.
doi: 10.1017/s0022172400025298.

e-Antigen: a link between immune response and infectivity in hepatitis B?

e-Antigen: a link between immune response and infectivity in hepatitis B?

G C Turner et al. J Hyg (Lond). 1978 Dec.

Abstract

In a study of the distribution of e-antigen and anti-e in subjects whose blood was positive for hepatitis B surface antigen (HBsAg), patients with acute hepatitis B who were tested during the incubation period were all e-antigen-positive but after the onset of illness e-antigen was detected in only 11%. Persistence, and in some instances reappearance of e-antigen in those who became long-term carriers of HBsAg was associated with high titres of HBsAg. There was a high incidence of e-antigen in those conditions in which cell-mediated immunity may be depressed, including Down's syndrome and chronic renal failure. The majority of HBsAg carries identified as sources of infection were e-antigen-positive. A postive reaction for e-antigen is evidently associated with a defective immune response to hepatitis B virus infection which permits continued replication of virus in liver cells accompanied by high titres of HBsAg, numerous Dane particles and detectable DNA polymerase in the blood with consequently a greater likelihood of transmitting infection. Although it cannot be assumed that anti-e positive carriers of HBsAg are not infective, it may be necessary, in the assessment of passive or active immunization for the control of hepatitis B, to take into account the e-antigen/antibody status of possible sources of infection.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Hyg (Lond). 1975 Feb;74(1):123-31 - PubMed
    1. Br Med J. 1971 Mar 6;1(5748):540-3 - PubMed
    1. Infect Immun. 1976 Jan;13(1):296-7 - PubMed
    1. Lancet. 1976 Feb 28;1(7957):486 - PubMed
    1. Lancet. 1976 Sep 11;2(7985):577 - PubMed

MeSH terms

Substances

LinkOut - more resources